Table 2 Validation of a cutoff value of 2.6937 for the neutrophil to lymphocyte ratio in predicting serious clinical outcomes for patients with COVID-19
Serious clinical outcomes | No. of patients | % (95% confidence interval) | |||
|---|---|---|---|---|---|
Sensitivity | Specificity | Positive predictive value | Negative predictive value | ||
Deterioration | 341 | 82.0 (69.0–91.0) | 69.1 (63.8–74.8) | 31.3 (23.4–39.7) | 95.7 (93.0–99.2) |
Shock | 338 | 93.3 (68.0–100) | 64.1 (58.9–69.7) | 10.8 (5.4–16.3) | 99.5 (98.6–100) |
Death | 341 | 92.9 (66.0–100) | 63.9 (58.7–69.5) | 9.9 (4.8–15.2) | 99.5 (98.6–100) |